Service & Software
Global Drug Repositioning Market Research Report 2025
- Apr 07, 25
- ID: 174630
- Pages: 83
- Figures: 85
- Views: 6
The global market for Drug Repositioning was valued at US$ 28780 million in the year 2024 and is projected to reach a revised size of US$ 39510 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
This report aims to provide a comprehensive presentation of the global market for Drug Repositioning, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repositioning.
The Drug Repositioning market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Repositioning market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repositioning companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Segment by Type
Generic Drugs
Clinical Trial Failed Drugs
Segment by Application
Cardiovascular Diseases
Mental Illness
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Repositioning company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
This report aims to provide a comprehensive presentation of the global market for Drug Repositioning, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repositioning.
The Drug Repositioning market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Repositioning market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repositioning companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Segment by Type
Generic Drugs
Clinical Trial Failed Drugs
Segment by Application
Cardiovascular Diseases
Mental Illness
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Repositioning company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Drug Repositioning Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repositioning Market Perspective (2020-2031)
2.2 Global Drug Repositioning Growth Trends by Region
2.2.1 Global Drug Repositioning Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Repositioning Historic Market Size by Region (2020-2025)
2.2.3 Drug Repositioning Forecasted Market Size by Region (2026-2031)
2.3 Drug Repositioning Market Dynamics
2.3.1 Drug Repositioning Industry Trends
2.3.2 Drug Repositioning Market Drivers
2.3.3 Drug Repositioning Market Challenges
2.3.4 Drug Repositioning Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repositioning Players by Revenue
3.1.1 Global Top Drug Repositioning Players by Revenue (2020-2025)
3.1.2 Global Drug Repositioning Revenue Market Share by Players (2020-2025)
3.2 Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Repositioning Revenue
3.4 Global Drug Repositioning Market Concentration Ratio
3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2024
3.5 Global Key Players of Drug Repositioning Head office and Area Served
3.6 Global Key Players of Drug Repositioning, Product and Application
3.7 Global Key Players of Drug Repositioning, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repositioning Breakdown Data by Type
4.1 Global Drug Repositioning Historic Market Size by Type (2020-2025)
4.2 Global Drug Repositioning Forecasted Market Size by Type (2026-2031)
5 Drug Repositioning Breakdown Data by Application
5.1 Global Drug Repositioning Historic Market Size by Application (2020-2025)
5.2 Global Drug Repositioning Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Repositioning Market Size (2020-2031)
6.2 North America Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Repositioning Market Size by Country (2020-2025)
6.4 North America Drug Repositioning Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Repositioning Market Size (2020-2031)
7.2 Europe Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Repositioning Market Size by Country (2020-2025)
7.4 Europe Drug Repositioning Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Repositioning Market Size (2020-2031)
8.2 Asia-Pacific Drug Repositioning Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Repositioning Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Repositioning Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Repositioning Market Size (2020-2031)
9.2 Latin America Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Repositioning Market Size by Country (2020-2025)
9.4 Latin America Drug Repositioning Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repositioning Market Size (2020-2031)
10.2 Middle East & Africa Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Repositioning Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Repositioning Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Drug Repositioning Introduction
11.1.4 Teva Revenue in Drug Repositioning Business (2020-2025)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Repositioning Introduction
11.2.4 Novartis Revenue in Drug Repositioning Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Drug Repositioning Introduction
11.3.4 Mylan Revenue in Drug Repositioning Business (2020-2025)
11.3.5 Mylan Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Drug Repositioning Introduction
11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Drug Repositioning Introduction
11.5.4 Pfizer Revenue in Drug Repositioning Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Drug Repositioning Introduction
11.6.4 Bausch Health Revenue in Drug Repositioning Business (2020-2025)
11.6.5 Bausch Health Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Drug Repositioning Introduction
11.7.4 GSK Revenue in Drug Repositioning Business (2020-2025)
11.7.5 GSK Recent Development
11.8 ChemRar Group
11.8.1 ChemRar Group Company Details
11.8.2 ChemRar Group Business Overview
11.8.3 ChemRar Group Drug Repositioning Introduction
11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2020-2025)
11.8.5 ChemRar Group Recent Development
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Glenmark Business Overview
11.9.3 Glenmark Drug Repositioning Introduction
11.9.4 Glenmark Revenue in Drug Repositioning Business (2020-2025)
11.9.5 Glenmark Recent Development
11.10 Fujifilm
11.10.1 Fujifilm Company Details
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Drug Repositioning Introduction
11.10.4 Fujifilm Revenue in Drug Repositioning Business (2020-2025)
11.10.5 Fujifilm Recent Development
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Drug Repositioning Introduction
11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2020-2025)
11.11.5 Dr. Reddy Recent Development
11.12 R-Pharma
11.12.1 R-Pharma Company Details
11.12.2 R-Pharma Business Overview
11.12.3 R-Pharma Drug Repositioning Introduction
11.12.4 R-Pharma Revenue in Drug Repositioning Business (2020-2025)
11.12.5 R-Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Drug Repositioning Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repositioning Market Perspective (2020-2031)
2.2 Global Drug Repositioning Growth Trends by Region
2.2.1 Global Drug Repositioning Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Repositioning Historic Market Size by Region (2020-2025)
2.2.3 Drug Repositioning Forecasted Market Size by Region (2026-2031)
2.3 Drug Repositioning Market Dynamics
2.3.1 Drug Repositioning Industry Trends
2.3.2 Drug Repositioning Market Drivers
2.3.3 Drug Repositioning Market Challenges
2.3.4 Drug Repositioning Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repositioning Players by Revenue
3.1.1 Global Top Drug Repositioning Players by Revenue (2020-2025)
3.1.2 Global Drug Repositioning Revenue Market Share by Players (2020-2025)
3.2 Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Repositioning Revenue
3.4 Global Drug Repositioning Market Concentration Ratio
3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2024
3.5 Global Key Players of Drug Repositioning Head office and Area Served
3.6 Global Key Players of Drug Repositioning, Product and Application
3.7 Global Key Players of Drug Repositioning, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repositioning Breakdown Data by Type
4.1 Global Drug Repositioning Historic Market Size by Type (2020-2025)
4.2 Global Drug Repositioning Forecasted Market Size by Type (2026-2031)
5 Drug Repositioning Breakdown Data by Application
5.1 Global Drug Repositioning Historic Market Size by Application (2020-2025)
5.2 Global Drug Repositioning Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Repositioning Market Size (2020-2031)
6.2 North America Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Repositioning Market Size by Country (2020-2025)
6.4 North America Drug Repositioning Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Repositioning Market Size (2020-2031)
7.2 Europe Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Repositioning Market Size by Country (2020-2025)
7.4 Europe Drug Repositioning Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Repositioning Market Size (2020-2031)
8.2 Asia-Pacific Drug Repositioning Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Repositioning Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Repositioning Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Repositioning Market Size (2020-2031)
9.2 Latin America Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Repositioning Market Size by Country (2020-2025)
9.4 Latin America Drug Repositioning Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repositioning Market Size (2020-2031)
10.2 Middle East & Africa Drug Repositioning Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Repositioning Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Repositioning Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Drug Repositioning Introduction
11.1.4 Teva Revenue in Drug Repositioning Business (2020-2025)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Repositioning Introduction
11.2.4 Novartis Revenue in Drug Repositioning Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Drug Repositioning Introduction
11.3.4 Mylan Revenue in Drug Repositioning Business (2020-2025)
11.3.5 Mylan Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Drug Repositioning Introduction
11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Drug Repositioning Introduction
11.5.4 Pfizer Revenue in Drug Repositioning Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Drug Repositioning Introduction
11.6.4 Bausch Health Revenue in Drug Repositioning Business (2020-2025)
11.6.5 Bausch Health Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Drug Repositioning Introduction
11.7.4 GSK Revenue in Drug Repositioning Business (2020-2025)
11.7.5 GSK Recent Development
11.8 ChemRar Group
11.8.1 ChemRar Group Company Details
11.8.2 ChemRar Group Business Overview
11.8.3 ChemRar Group Drug Repositioning Introduction
11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2020-2025)
11.8.5 ChemRar Group Recent Development
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Glenmark Business Overview
11.9.3 Glenmark Drug Repositioning Introduction
11.9.4 Glenmark Revenue in Drug Repositioning Business (2020-2025)
11.9.5 Glenmark Recent Development
11.10 Fujifilm
11.10.1 Fujifilm Company Details
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Drug Repositioning Introduction
11.10.4 Fujifilm Revenue in Drug Repositioning Business (2020-2025)
11.10.5 Fujifilm Recent Development
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Drug Repositioning Introduction
11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2020-2025)
11.11.5 Dr. Reddy Recent Development
11.12 R-Pharma
11.12.1 R-Pharma Company Details
11.12.2 R-Pharma Business Overview
11.12.3 R-Pharma Drug Repositioning Introduction
11.12.4 R-Pharma Revenue in Drug Repositioning Business (2020-2025)
11.12.5 R-Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Generic Drugs
Table 3. Key Players of Clinical Trial Failed Drugs
Table 4. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug Repositioning Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Repositioning Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug Repositioning Market Share by Region (2020-2025)
Table 8. Global Drug Repositioning Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug Repositioning Market Share by Region (2026-2031)
Table 10. Drug Repositioning Market Trends
Table 11. Drug Repositioning Market Drivers
Table 12. Drug Repositioning Market Challenges
Table 13. Drug Repositioning Market Restraints
Table 14. Global Drug Repositioning Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug Repositioning Market Share by Players (2020-2025)
Table 16. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2024)
Table 17. Ranking of Global Top Drug Repositioning Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug Repositioning, Headquarters and Area Served
Table 20. Global Key Players of Drug Repositioning, Product and Application
Table 21. Global Key Players of Drug Repositioning, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug Repositioning Revenue Market Share by Type (2020-2025)
Table 25. Global Drug Repositioning Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Repositioning Revenue Market Share by Type (2026-2031)
Table 27. Global Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug Repositioning Revenue Market Share by Application (2020-2025)
Table 29. Global Drug Repositioning Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug Repositioning Revenue Market Share by Application (2026-2031)
Table 31. North America Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug Repositioning Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug Repositioning Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug Repositioning Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 46. Teva Company Details
Table 47. Teva Business Overview
Table 48. Teva Drug Repositioning Product
Table 49. Teva Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 50. Teva Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Drug Repositioning Product
Table 54. Novartis Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Mylan Company Details
Table 57. Mylan Business Overview
Table 58. Mylan Drug Repositioning Product
Table 59. Mylan Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 60. Mylan Recent Development
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Drug Repositioning Product
Table 64. Johnson & Johnson Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Drug Repositioning Product
Table 69. Pfizer Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Bausch Health Company Details
Table 72. Bausch Health Business Overview
Table 73. Bausch Health Drug Repositioning Product
Table 74. Bausch Health Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 75. Bausch Health Recent Development
Table 76. GSK Company Details
Table 77. GSK Business Overview
Table 78. GSK Drug Repositioning Product
Table 79. GSK Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 80. GSK Recent Development
Table 81. ChemRar Group Company Details
Table 82. ChemRar Group Business Overview
Table 83. ChemRar Group Drug Repositioning Product
Table 84. ChemRar Group Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 85. ChemRar Group Recent Development
Table 86. Glenmark Company Details
Table 87. Glenmark Business Overview
Table 88. Glenmark Drug Repositioning Product
Table 89. Glenmark Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 90. Glenmark Recent Development
Table 91. Fujifilm Company Details
Table 92. Fujifilm Business Overview
Table 93. Fujifilm Drug Repositioning Product
Table 94. Fujifilm Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 95. Fujifilm Recent Development
Table 96. Dr. Reddy Company Details
Table 97. Dr. Reddy Business Overview
Table 98. Dr. Reddy Drug Repositioning Product
Table 99. Dr. Reddy Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 100. Dr. Reddy Recent Development
Table 101. R-Pharma Company Details
Table 102. R-Pharma Business Overview
Table 103. R-Pharma Drug Repositioning Product
Table 104. R-Pharma Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 105. R-Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Drug Repositioning Picture
Figure 2. Global Drug Repositioning Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Repositioning Market Share by Type: 2024 VS 2031
Figure 4. Generic Drugs Features
Figure 5. Clinical Trial Failed Drugs Features
Figure 6. Global Drug Repositioning Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Repositioning Market Share by Application: 2024 VS 2031
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Mental Illness Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Repositioning Report Years Considered
Figure 13. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Drug Repositioning Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drug Repositioning Market Share by Region: 2024 VS 2031
Figure 16. Global Drug Repositioning Market Share by Players in 2024
Figure 17. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2024
Figure 19. North America Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Drug Repositioning Market Share by Country (2020-2031)
Figure 21. United States Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug Repositioning Market Share by Country (2020-2031)
Figure 25. Germany Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug Repositioning Market Share by Region (2020-2031)
Figure 33. China Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug Repositioning Market Share by Country (2020-2031)
Figure 41. Mexico Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug Repositioning Market Share by Country (2020-2031)
Figure 45. Turkey Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Teva Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 49. Novartis Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 50. Mylan Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 53. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 55. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 56. Glenmark Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 57. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 58. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 59. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Generic Drugs
Table 3. Key Players of Clinical Trial Failed Drugs
Table 4. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug Repositioning Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Repositioning Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug Repositioning Market Share by Region (2020-2025)
Table 8. Global Drug Repositioning Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug Repositioning Market Share by Region (2026-2031)
Table 10. Drug Repositioning Market Trends
Table 11. Drug Repositioning Market Drivers
Table 12. Drug Repositioning Market Challenges
Table 13. Drug Repositioning Market Restraints
Table 14. Global Drug Repositioning Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug Repositioning Market Share by Players (2020-2025)
Table 16. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2024)
Table 17. Ranking of Global Top Drug Repositioning Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug Repositioning, Headquarters and Area Served
Table 20. Global Key Players of Drug Repositioning, Product and Application
Table 21. Global Key Players of Drug Repositioning, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug Repositioning Revenue Market Share by Type (2020-2025)
Table 25. Global Drug Repositioning Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Repositioning Revenue Market Share by Type (2026-2031)
Table 27. Global Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug Repositioning Revenue Market Share by Application (2020-2025)
Table 29. Global Drug Repositioning Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug Repositioning Revenue Market Share by Application (2026-2031)
Table 31. North America Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug Repositioning Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug Repositioning Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug Repositioning Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug Repositioning Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug Repositioning Market Size by Country (2026-2031) & (US$ Million)
Table 46. Teva Company Details
Table 47. Teva Business Overview
Table 48. Teva Drug Repositioning Product
Table 49. Teva Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 50. Teva Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Drug Repositioning Product
Table 54. Novartis Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Mylan Company Details
Table 57. Mylan Business Overview
Table 58. Mylan Drug Repositioning Product
Table 59. Mylan Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 60. Mylan Recent Development
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Drug Repositioning Product
Table 64. Johnson & Johnson Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Drug Repositioning Product
Table 69. Pfizer Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Bausch Health Company Details
Table 72. Bausch Health Business Overview
Table 73. Bausch Health Drug Repositioning Product
Table 74. Bausch Health Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 75. Bausch Health Recent Development
Table 76. GSK Company Details
Table 77. GSK Business Overview
Table 78. GSK Drug Repositioning Product
Table 79. GSK Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 80. GSK Recent Development
Table 81. ChemRar Group Company Details
Table 82. ChemRar Group Business Overview
Table 83. ChemRar Group Drug Repositioning Product
Table 84. ChemRar Group Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 85. ChemRar Group Recent Development
Table 86. Glenmark Company Details
Table 87. Glenmark Business Overview
Table 88. Glenmark Drug Repositioning Product
Table 89. Glenmark Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 90. Glenmark Recent Development
Table 91. Fujifilm Company Details
Table 92. Fujifilm Business Overview
Table 93. Fujifilm Drug Repositioning Product
Table 94. Fujifilm Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 95. Fujifilm Recent Development
Table 96. Dr. Reddy Company Details
Table 97. Dr. Reddy Business Overview
Table 98. Dr. Reddy Drug Repositioning Product
Table 99. Dr. Reddy Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 100. Dr. Reddy Recent Development
Table 101. R-Pharma Company Details
Table 102. R-Pharma Business Overview
Table 103. R-Pharma Drug Repositioning Product
Table 104. R-Pharma Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 105. R-Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Drug Repositioning Picture
Figure 2. Global Drug Repositioning Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Repositioning Market Share by Type: 2024 VS 2031
Figure 4. Generic Drugs Features
Figure 5. Clinical Trial Failed Drugs Features
Figure 6. Global Drug Repositioning Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Repositioning Market Share by Application: 2024 VS 2031
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Mental Illness Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Repositioning Report Years Considered
Figure 13. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Drug Repositioning Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drug Repositioning Market Share by Region: 2024 VS 2031
Figure 16. Global Drug Repositioning Market Share by Players in 2024
Figure 17. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2024
Figure 19. North America Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Drug Repositioning Market Share by Country (2020-2031)
Figure 21. United States Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug Repositioning Market Share by Country (2020-2031)
Figure 25. Germany Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug Repositioning Market Share by Region (2020-2031)
Figure 33. China Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug Repositioning Market Share by Country (2020-2031)
Figure 41. Mexico Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug Repositioning Market Share by Country (2020-2031)
Figure 45. Turkey Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Drug Repositioning Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Teva Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 49. Novartis Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 50. Mylan Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 53. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 55. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 56. Glenmark Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 57. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 58. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 59. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232